Structure-guided optimization of quinoline inhibitors of Plasmodium N-myristoyltransferase.

ABSTRACT: The parasite Plasmodium vivax is the most widely distributed cause of recurring malaria. N-Myristoyltransferase (NMT), an enzyme that catalyses the covalent attachment of myristate to the N-terminal glycine of substrate proteins, has been described as a potential target for the treatment of this disease. Herein, we report the synthesis and the structure-guided optimization of a series of quinolines with balanced activity against both Plasmodium vivax and Plasmodium falciparum N-myristoyltransferase (NMT).

SUBMITTER: Goncalves V 

PROVIDER: S-EPMC5463734 | biostudies-literature |

REPOSITORIES: biostudies-literature